Revvity Bundle
Who Really Owns Revvity?
Unraveling the Revvity SWOT Analysis and understanding its ownership is key to navigating the complex landscape of the life sciences and diagnostics industry. Following its spin-off from PerkinElmer in May 2023, Revvity emerged as a distinct entity, sparking curiosity about its new ownership structure and strategic direction. This transformation raises critical questions about the company's future, its major stakeholders, and the influence shaping its trajectory.
As a publicly traded company under the symbol 'RVTY' on the NYSE, understanding the intricacies of Revvity ownership is crucial for investors and industry observers alike. This report will explore the evolution of Revvity's ownership, including its foundational structure, major institutional and individual stakeholders, and recent trends impacting its profile. Discover the answers to questions like "Who owns Revvity?" and "Who is the CEO of Revvity?" to gain a comprehensive understanding of this dynamic company.
Who Founded Revvity?
Understanding the ownership of the [Company Name] requires looking back to its origins. Unlike a typical startup with individual founders, Revvity emerged as a spin-off from PerkinElmer, Inc. in May 2023. This unique structure shaped its initial ownership and subsequent development.
The separation of PerkinElmer into two distinct entities was a strategic decision. This resulted in Revvity, focusing on life sciences and diagnostics, and the remaining businesses, which were acquired by New Mountain Capital. This spin-off model directly influenced who owns Revvity and its initial ownership structure.
Prahlad Singh, who had been the President and CEO of PerkinElmer since early 2020, continued in the same role at Revvity post-spin-off. Other key executives also transitioned, ensuring continuity in leadership. The new company's ownership was distributed among the existing PerkinElmer shareholders at the time of the separation.
Revvity's creation was a spin-off, not a startup. This means its initial ownership was determined by the existing shareholders of PerkinElmer.
Prahlad Singh, the former CEO of PerkinElmer, continued to lead Revvity. This provided stability during the transition.
The initial ownership was a pro-rata distribution to PerkinElmer shareholders. There were no early investors in the traditional sense.
The spin-off aimed to create a more focused health science solutions company. This strategic goal shaped the early agreements and vision.
Revvity began as a public company. Its shares were distributed to existing PerkinElmer shareholders.
Unlike startups, Revvity did not have angel investors or friends and family acquiring stakes. The ownership was based on the existing shareholder base.
The formation of Revvity and its subsequent ownership structure highlight a unique path. The company's history is tied to PerkinElmer's strategic decisions. To gain a deeper understanding of the market, you can explore the Target Market of Revvity. As of the latest financial reports, Revvity's market capitalization reflects its position in the life sciences and diagnostics sector. The company's major shareholders and their respective stakes are detailed in public filings, offering insights into the current Revvity ownership structure. Furthermore, understanding Revvity's business segments helps to analyze its financial performance and overall company strategy.
Revvity SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Revvity’s Ownership Changed Over Time?
The ownership structure of Revvity, a publicly traded company, has been significantly shaped by its spin-off from PerkinElmer in May 2023. Since then, the company has been listed on the NYSE under the ticker RVTY, marking a pivotal shift in its ownership dynamics. This event established Revvity as an independent entity, attracting a diverse range of investors and setting the stage for its current ownership composition.
As of June 12, 2025, the market capitalization of Revvity is approximately $11 billion, with roughly 118 million shares outstanding. The ownership is distributed among institutional investors, retail investors, and company insiders. The company's ownership structure continues to evolve, reflecting shifts in investment strategies and market dynamics, influencing the company's strategic direction and governance.
| Ownership Category | Percentage | Notes |
|---|---|---|
| Institutional Investors | 62.59% (Recent Data) | Significant influence on company strategy and governance. |
| Retail Investors | 37.03% | Includes public companies and individual investors. |
| Insiders | 0.38% | Company executives and directors. |
Institutional investors, such as T. Rowe Price Investment Management, Inc., Vanguard Group Inc, and BlackRock, Inc., hold a substantial portion of Revvity's stock. For instance, T. Rowe Price Capital Appreciation Fund, Inc. holds approximately 11.16% of the company's stock, valued at over $1.2 billion. Vanguard Index Funds and Vanguard also maintain significant stakes. These large institutional holdings provide insights into the company's investor base and its influence on the company's strategic decisions. Regular filings, such as Schedule 13G/A forms, reveal ongoing adjustments in portfolio allocations by major funds, impacting the company's strategy and governance.
The ownership of Revvity is primarily composed of institutional and retail investors, with a smaller percentage held by insiders. Institutional investors hold the majority of the stock, influencing strategic decisions. This structure is a key aspect of understanding the Revvity ownership.
- Institutional investors hold a significant portion of shares.
- Retail investors also contribute to the ownership structure.
- Insiders, including executives, hold a smaller percentage.
- The Revvity owner base is diverse.
Revvity PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Revvity’s Board?
The current Board of Directors at Revvity plays a vital role in overseeing the company's strategy and governance. According to the company's bylaws, the number of directors can range from three to thirteen, as determined by shareholder or director vote. The Board typically aims to have between seven and ten members. As of the 2024 proxy statement, the board comprised eleven directors, with ten being independent, and included an independent Chairman. The company's structure and leadership are key aspects of understanding Revvity ownership.
The voting structure for electing directors in uncontested elections follows a majority of votes cast standard. This means a nominee is elected if they receive more 'for' votes than 'against' votes. Each share of common stock is entitled to one vote, and there is no cumulative voting. Procedures for contested elections are also in place, where a plurality of votes cast would apply. Understanding the Revvity owner and the board's composition is crucial for investors and stakeholders. For a deeper dive, you might find insights in the Competitors Landscape of Revvity.
| Director | Position | Independent |
|---|---|---|
| Prahlad Singh | President and CEO | No |
| Alexis Michas | Director | Yes |
| ... | ... | ... |
Board members are nominated annually by the Board, with the Nominating and Corporate Governance Committee screening candidates. The Board expects each Director to hold a meaningful amount of company stock. Recent filings show insider trading activity, including stock awards to CEO Prahlad Singh in February 2025, and sales by Director Alexis Michas in August 2024. The governance framework includes annual board self-evaluations and regular reviews of director independence. There are no dual-class shares or special voting rights that would give certain individuals or entities outsized control beyond their shareholding percentage. Proxy statements, such as the DEF 14A filed in March 2025, detail shareholder votes, including director elections and the ratification of the independent registered public accounting firm. This structure is important for anyone researching Revvity company.
The Board of Directors at Revvity is structured to ensure independent oversight and strategic direction, with a majority of independent directors. The voting system is straightforward, with one vote per share, and elections are based on a majority vote in uncontested scenarios. Insider trading activities and stock ownership targets are part of the governance framework.
- The Board consists of eleven directors as of the 2024 proxy statement.
- Voting is based on one vote per share, with a majority vote standard.
- The company's governance includes annual self-evaluations.
- Insider trading activity is reported in SEC filings.
Revvity Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Revvity’s Ownership Landscape?
Over the past few years, the Revvity ownership structure has been significantly impacted by its spin-off from PerkinElmer in May 2023. This strategic move established Revvity as an independent, publicly traded entity, focusing on life sciences and diagnostics. The company's primary goal with this transformation was to unlock value and sharpen its focus within its core markets. This shift has led to notable changes in the company's ownership profile and strategic direction.
In terms of capital allocation, Revvity has actively engaged in share repurchase programs, reflecting a commitment to returning value to shareholders. In November 2024, the Board of Directors authorized a new two-year $1 billion share repurchase program, replacing a previous program. Between January 1, 2025, and May 6, 2025, the company repurchased 2,886,436 shares, representing 2.39% of its stock, for $300.05 million. This completed the repurchase of 4,125,191 shares for $444.25 million under the November 2024 program. These buybacks can reduce the number of outstanding shares, potentially increasing the proportional ownership of remaining shareholders.
| Ownership Metric | Details | As of |
|---|---|---|
| Institutional Ownership | Approximately 62.59% of stock | Recent Data |
| Institutional Holdings Unchanged | 97.88% | May 2025 |
| Insider Ownership | Around 0.38% | Recent Data |
Institutional investors continue to hold a significant position in Revvity stock, demonstrating confidence in the company's prospects. Major institutional investors regularly adjust their holdings, as observed in recent hedge fund trading activity in March 2025. Insider ownership, though relatively small, also experiences periodic changes through stock awards and sales. The company's strategic acquisitions, such as BioLegend, Nexcelom, and Oxford Immunotec, have broadened its offerings and strengthened its presence in high-growth markets. For a deeper dive into Revvity's strategic initiatives, consider reading about the Growth Strategy of Revvity.
Revvity's ownership is primarily characterized by institutional investors, who hold a significant portion of the company's stock. Insider ownership is present but represents a smaller percentage. The company's shift to a publicly traded entity has shaped its ownership dynamics.
Revvity has been actively involved in share repurchase programs, with a new $1 billion program authorized in November 2024. These programs aim to return value to shareholders and can impact the proportional ownership of existing investors. The company repurchased a significant number of shares by May 2025.
Revvity has strategically acquired companies like BioLegend, Nexcelom, and Oxford Immunotec to expand its offerings. These acquisitions have strengthened its position in high-growth markets and broadened its portfolio. This is a key part of the Revvity company strategy.
For 2025, Revvity projects a revenue growth of 2.54% and an adjusted EPS increase of 1.02%. The company has also updated its organizational structure effective fiscal year 2025 to streamline operations and enhance customer focus. The Revvity stock shows a positive outlook.
Revvity Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Revvity Company?
- What is Competitive Landscape of Revvity Company?
- What is Growth Strategy and Future Prospects of Revvity Company?
- How Does Revvity Company Work?
- What is Sales and Marketing Strategy of Revvity Company?
- What is Brief History of Revvity Company?
- What is Customer Demographics and Target Market of Revvity Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.